Dopamine receptors in the denervated striatum: further supersensitivity by chronic haloperidol treatment.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Brain Research

• Publication date

  1983-09-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-8993(83)90434-1PMID 6414646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa

  1982cited by this paper
• Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive

  1982cited by this paper
• 3‐O‐Methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway

  1982cited by this paper
• The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.

  1982cited by this paper
• Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig.

  1981cited by this paper
• Increase in mesolimbic electrical self-stimulation after chronic haloperidol: reversal by L-DOPA or lithium.

  1981cited by this paper
• Receptor adaptations to centrally acting drugs.

  1981cited by this paper
• Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior.

  1981cited by this paper
• The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig.

  1981cited by this paper
• Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.

  1980cited by this paper
• Turning behaviour in animals.

  1980cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes.

  1980cited by this paper
• Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.

  1979cited by this paper
• Dopaminergic supersensitivity: Influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia

  1979cited by this paper
• Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.

  1979cited by this paper
• L-DOPA reversal of hyperdopaminergic behaviour.

  1978cited by this paper
• Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors.

  1978cited by this paper
• Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease.

  1977cited by this paper
• Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.

  1977cited by this paper
• Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.

  1977cited by this paper
• Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

  1977cited by this paper
• Central dopaminergic receptor supersensitivity and its relevance to Parkinson's disease

  1977cited by this paper
• Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum

  1975cited by this paper
• Stereotaxic mapping of the monoamine pathways in the rat brain.

  1971cited by this paper
• Supersensitivity following "pharmacological denervation".

  1961cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• EFFECTS OF REPEATED ARIPIPRAZOLE TREATMENT ON THE cAMP AND AKT PATHWAYS IN THE DORSAL STRIATUM OF PREADOLESCENT AND ADULT RATS

  2016cites this paper
• Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations

  2005cites this paper
• L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum

  2005cites this paper
• Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats

  2005cites this paper
• Regulation of Dopamine Receptor Function and Expression

  1997cites this paper
• Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.

  1996cites this paper
• Neuroleptics Up‐Regulate Adenosine A2a Receptors in Rat Striatum: Implications for the Mechanism and the Treatment of Tardive Dyskinesia

  1995cites this paper
• The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals.

  1994cites this paper
• Dopamine receptors in Parkinson's disease.

  1992cites this paper
• Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission

  1992cites this paper
• Neuropeptide Y Neurons in the Striatal Network. Functional Adaptive Responses to Impairment of Striatal Inputs

  1991cites this paper
• Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.

  1991cites this paper
• Cortical Regulation of Striatal Neuropeptide Y (NPY)‐Containing Neurons in the Rat

  1990cites this paper
• Dependence of effects of the tripeptide MIF and lithium chloride on degree of supersensitivity of brain dopamine receptors

  1989cites this paper
• Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.

  1989cites this paper
• Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist.

  1989cites this paper
• Behavioral and biochemical effects of intranigral injection of phospholipase-A2.

  1989cites this paper
• Effect of chronic administration of the converting enzyme inhibitor enalapril (MK 421) on brain atrial natriuretic peptide receptors in Wistar-Kyoto and spontaneously hypertensive rats.

  1988cites this paper
• Schizophrénie: l'hypothèse dopaminergique à l'épreuve de la génétique moléculaire. I

  1988cites this paper
• Embryonic Substantia Nigra Grafts

  1987cites this paper
• Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.

  1987cites this paper
• Embryonic substantia nigra grafts. Factors controlling behavioral efficacy and reinnervation of the host striatum.

  1987cites this paper
• Relationship Between Dopamine Receptor Occupation by Spiperone and Acetylcholine Levels in the Rat Striatum After Long‐Term Haloperidol Treatment Depends on Dopamine Innervation

  1987cites this paper
• Further dopaminergic supersensitivity to dopamine agonists by subchronic administration of haloperidol in rats treated with colchicine.

  1986cites this paper
• Dopamine D2 receptor density remains constant in treated Parkinson's disease

  1986cites this paper
• Hypophysectomy does not alter the increase in striatal dopamine receptor density produced by 6-hydroxydopamine lesions in male rats.

  1986cites this paper
• Reserpine-induced up-regulation of dopamine D2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade.

  1986cites this paper
• γ‐Aminobutyric Acid and Benzodiazepine Receptor Changes Induced by Unilateral 6‐Hydroxydopamine Lesions of the Medial Forebrain Bundle

  1985cites this paper
• Presynaptic inhibition of dopamine synthesis in rat striatum: effects of chronic dopamine depletion and receptor blockade.

  1985cites this paper
• Cognitive performance of medicated schizophrenics with tardive dyskinesia

  1985cites this paper
• The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.

  1985cites this paper
• Changes of the striatal 3H-spiperone binding 3-6 weeks after nigrostriatal denervation and after two years.

  1985cites this paper
• The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.

  1984cites this paper
• Chronic levodopa or pergolide administration induces down‐regulation of dopamine receptors in denervated striatum

  1984cites this paper